Cronos (CRON) Non Operating Income (2019 - 2026)
Cronos' (CRON) quarterly Non Operating Income came in at $20.0 million in Q1 2026, up 76.12% year-on-year from $11.3 million in Q1 2025, and up 508.43% quarter-over-quarter from -$4.9 million in Q4 2025.
Cronos (CRON) Non Operating Income (2019 - 2026) Analysis & Trends
Cronos' Non Operating Income history runs 8 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- On a quarterly basis, Non Operating Income rose 76.12% year-over-year to $20.0 million in Q1 2026; TTM through Mar 2026 was $8.9 million, a 81.86% decrease from a year earlier, with the FY2025 full-year figure at $275000.0, down 99.47% from the prior year.
- Non Operating Income advanced to $20.0 million in Q1 2026 per CRON's latest filing, from -$4.9 million in the prior quarter.
- Across five years, Non Operating Income topped out at $38.3 million in Q3 2024 and bottomed at -$33.7 million in Q2 2025.
- The 5-year median for Non Operating Income is $11.3 million (2025), against an average of $6.2 million.
- Across the five-year window, Non Operating Income jumped 997.46% in 2024 and tumbled 350.41% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$17.1 million in 2022, then surged by 194.65% to $16.2 million in 2023, then plunged by 185.94% to -$13.9 million in 2024, then surged by 64.94% to -$4.9 million in 2025, then jumped by 508.43% to $20.0 million in 2026.
- Per Business Quant, the three latest CRON Non Operating Income figures stand at $20.0 million (Q1 2026), -$4.9 million (Q4 2025), and $27.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.97 Mn |
| Dec 31, 2025 | -4.89 Mn |
| Sep 30, 2025 | 27.51 Mn |
| Jun 30, 2025 | -33.68 Mn |
| Mar 31, 2025 | 11.34 Mn |
| Dec 31, 2024 | -13.95 Mn |
| Sep 30, 2024 | 38.27 Mn |
| Jun 30, 2024 | 13.45 Mn |
| Mar 31, 2024 | 14.25 Mn |
| Dec 31, 2023 | 16.23 Mn |
| Sep 30, 2023 | 13.38 Mn |
| Jun 30, 2023 | 12.47 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | -17.15 Mn |
| Sep 30, 2022 | -3.65 Mn |
| Jun 30, 2022 | 7.47 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | -125.92 Mn |
| Sep 30, 2021 | 133.84 Mn |
| Jun 30, 2021 | 117.55 Mn |